Shlomit Strulov Shachar

Shlomit Strulov Shachar

Tel Aviv Medical Center - Tel Aviv / Israel
Others
AD Scientific Index ID: 4704085
person_outline Shlomit Strulov Shachar's MOST POPULAR ARTICLES
1-) Tucatinib, trastuzumab, and capecitabine for HER2-positive metastatic breast cancer New England Journal of Medicine 382 (7), 597-609, 2020
2-) Prognostic value of sarcopenia in adults with solid tumours: a meta-analysis and systematic review European journal of cancer 57, 58-67, 2016
3-) Prognostic value of lymphocyte-to-monocyte ratio in patients with solid tumors: a systematic review and meta-analysis Cancer treatment reviews 41 (10), 971-978, 2015
4-) Safety and tolerability of PD‐1/PD‐L1 inhibitors compared with chemotherapy in patients with advanced cancer: a meta‐analysis The oncologist 22 (4), 470-479, 2017
5-) Skeletal muscle measures as predictors of toxicity, hospitalization, and survival in patients with metastatic breast cancer receiving taxane-based chemotherapy Clinical Cancer Research 23 (3), 658-665, 2017